Fractyl Health (GUTS) Return on Sales (2023 - 2025)
Historic Return on Sales for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to 8161.33%.
- Fractyl Health's Return on Sales fell 65294000.0% to 8161.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 8161.33%, marking a year-over-year decrease of 73632000.0%. This contributed to the annual value of 961.13% for FY2024, which is 5480000.0% down from last year.
- Per Fractyl Health's latest filing, its Return on Sales stood at 8161.33% for Q3 2025, which was down 65294000.0% from 2784.18% recorded in Q2 2025.
- Fractyl Health's Return on Sales' 5-year high stood at 162.79% during Q2 2023, with a 5-year trough of 8161.33% in Q4 2024.
- Over the past 3 years, Fractyl Health's median Return on Sales value was 1631.93% (recorded in 2024), while the average stood at 2516.18%.
- Its Return on Sales has fluctuated over the past 5 years, first soared by 17184800bps in 2024, then plummeted by -65294000bps in 2025.
- Fractyl Health's Return on Sales (Quarter) stood at 1788.29% in 2023, then tumbled by -356bps to 8161.33% in 2024, then changed by 0bps to 8161.33% in 2025.
- Its Return on Sales stands at 8161.33% for Q3 2025, versus 2784.18% for Q2 2025 and 1149.02% for Q1 2025.